Stockscreener 앱 받기
10.27
3.27%
0.325
전일 마감가:
$9.94
열려 있는:
$9.98
하루 거래량:
15,063
Relative Volume:
0.56
시가총액:
$73.61M
수익:
-
순이익/손실:
$-61.23M
주가수익비율:
-0.7593
EPS:
-13.5194
순현금흐름:
$22.49M
1주 성능:
+4.64%
1개월 성능:
-6.77%
6개월 성능:
-38.86%
1년 성능:
-22.35%
1일 변동 폭
$9.82
$10.40
1주일 범위
$9.68
$10.78
52주 변동 폭
$7.75
$19.93
Assembly Biosciences Inc Stock (ASMB) Company Profile
명칭
Assembly Biosciences Inc
전화
(833) 409-4583
주소
TWO TOWER PLACE, SOUTH SAN FRANCISCO
ASMB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
10.08 | 73.61M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.14 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
582.37 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
599.96 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.63 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.00 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-25 | 개시 | Guggenheim | Buy |
| 2024-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-09-13 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-02 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-10-19 | 개시 | Truist | Buy |
| 2019-10-16 | 개시 | Mizuho | Buy |
| 2018-11-19 | 개시 | Leerink Partners | Outperform |
| 2018-10-08 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | 개시 | Robert W. Baird | Outperform |
| 2018-04-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | 개시 | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | 개시 | Jefferies | Buy |
| 2017-05-30 | 개시 | Chardan Capital Markets | Buy |
모두보기
Assembly Biosciences Inc 주식(ASMB)의 최신 뉴스
Long Term Trading Analysis for (ASMB) - news.stocktradersdaily.com
Assembly Biosciences director sells $7,455 in stock - Investing.com Australia
Assembly Biosciences director sells $7,455 in stock By Investing.com - Investing.com South Africa
Assembly Biosciences Presents New Data Highlighting Long-Acting - GuruFocus
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress - The Manila Times
Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround - Yahoo Finance
ASMB stock touches 52-week low at $8.21 amid market challenges - Investing.com
ASMB stock touches 52-week low at $8.21 amid market challenges By Investing.com - Investing.com South Africa
Mastercard Is Taking On the World and Winning - The Globe and Mail
Assembly Biosciences, Inc. (NASDAQ:ASMB) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough - simplywall.st
(ASMB) Investment Report - news.stocktradersdaily.com
Consumer Internet Stocks Q4 Teardown: Remitly (NASDAQ:RELY) Vs The Rest - The Globe and Mail
Assembly Biosciences CEO sells shares worth $3,496 By Investing.com - Investing.com Canada
Assembly Biosciences officer sells $1,772 in stock By Investing.com - Investing.com South Africa
Assembly Biosciences CEO sells shares worth $3,496 - Investing.com
Assembly Biosciences officer sells shares for $1,940 - Investing.com India
Assembly Biosciences officer sells $1,772 in stock - Investing.com India
Five9 (FIVN): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail
ASMB stock touches 52-week low at $10.1 amid market challenges - Investing.com
Q4 Earnings Outperformers: Fastenal (NASDAQ:FAST) And The Rest Of The Maintenance and Repair Distributors Stocks - The Globe and Mail
Assembly Biosciences (ASMB) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Research Analysts Offer Predictions for ASMB Q1 Earnings - Defense World
Guggenheim Initiates Coverage of Assembly Biosciences (ASMB) with Buy Recommendation - MSN
Research Analysts Issue Forecasts for ASMB FY2029 Earnings - Defense World
Assembly Biosciences (NASDAQ:ASMB) Now Covered by Guggenheim - Defense World
Assembly Biosciences Reports 2024 Financial Results and Progress - TipRanks
This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Guggenheim Initiates Assembly Biosciences at Buy With $31 Price Target - MarketScreener
Assembly Biosciences (NASDAQ:ASMB) Lowered to Hold Rating by StockNews.com - Defense World
Assembly Biosciences (NASDAQ:ASMB) Receives “Neutral” Rating from HC Wainwright - Defense World
Assembly Biosciences: 2024 Earnings Surge, Pipeline Promises - AInvest
Assembly Biosciences Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Assembly Biosciences Inc Reports Annual EPS of -$6.69 and Revenue of $28.5 Million, Surpassing Estimates - GuruFocus
3 Reasons LNW is Risky and 1 Stock to Buy Instead - The Globe and Mail
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Update - Defense World
Assembly Biosciences Inc Files For Mixed Shelf Offering Of Up To $250 Million -March 20, 2025 at 05:09 pm EDT - Marketscreener.com
Assembly Biosciences Inc. (ASMB) reports earnings - Quartz
Assembly Biosciences FY Net Income USD 40.177 Million -March 20, 2025 at 04:53 pm EDT - Marketscreener.com
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights - The Manila Times
ASSEMBLY BIOSCIENCES, INC. SEC 10-K Report - TradingView
Assembly Biosciences (ASMB) to Release Earnings on Thursday - Defense World
Assembly Biosciences Insiders Placed Bullish Bets Worth US$679.4k - Yahoo
(ASMB) Proactive Strategies - news.stocktradersdaily.com
ASMB stock touches 52-week low at $10.8 amid market challenges - Investing.com Australia
ASMB stock touches 52-week low at $10.8 amid market challenges By Investing.com - Investing.com South Africa
Assembly Biosciences Inc (ASMB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.75%
2.22%
자본화:
|
볼륨(24시간):